1. Yoko Yanagisawa is a clinical research fellow in the Department of Clinical Pharmacology at the University of Oxford. Her main research interest is in the identification of biomarkers of colorectal cancer.
2. Rachel Midgley gained a GSc (Physiology) and MBChB with Honours from University of Birmingham. After general medical post-graduate training (MRCP) she undertook research into cancer vaccines, leading to the award of her PhD in 2002. She is developing her academic interest in colorectal cancer adjuvant therapy and post-doctorral research in immunotherapy
3. David Kerr is Rhodes Professor of Clinical Pharmacology and Cancer Therapeutics at the Department of Clinical Pharmacology, Fellow of Corpus Christi College, University of Oxford. He has an international reputation for the treatment of and research into colorectal cancer, and is developing new approaches to cancer treatment that involve novel inhibitors of key biochemical pathways. He has published more than 350 articles in peer-reviewed journals and has contributed to many books on cancer. David Kerr...